Autoimmunity (Organ-specific autoimmune disease) Flashcards

(80 cards)

1
Q

diseases in which immune response is directed against self-antigens that are mainly found in a single organ/gland

A

Organ-Specific Autoimmune Diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

2 Autoimmune Thyroid Disease (AITDS)

A

Hashimoto’s thyroiditis (Chronic lymphocytic thyroiditis)
Graves disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

associated alleles/HLA antigens in Hashimoto’s thyroiditis

A

HLA antigens DR3, DR4, DR5, DQ7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

associated allele/HLA antigen in Graves dse

A

HLA-DR3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

formed antibodies from the mutations in the thyroglobulin gene that allow for interaction of protein with HLADR antigens

A

antithyroglobulin antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

history of Chronic lymphocytic thyroiditis

A

Japan, 1912
Dr. Hakaru Hashimoto

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

most common autoimmune disease; what is the proportion?; W:M?

A

Hashimoto’s Thyroiditis (Chronic lymphocytic thyroiditis)
8 in every 1,000
5-10:1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

condition with a production of thyroid-specific autoantibodies and cytotoxic T cells

A

Hashimoto’s Thyroiditis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

associated with hypothyroidism

A

Hashimoto’s Thyroiditis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

S/S:
dry skin
decreased sweating
puffy face with edematous eyelids
pallor with a yellow tinge
weight gain
fatigue
dry and brittle hair

A

Hashimoto’s Thyroiditis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

assoc with hyperthyroidism

A

Graves Disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

S/S:
nervousness
insomnia
depression
weight loss
heat intolerance
sweating
rapid heartbeat
palpitations
breathlessness
fatigue
cardiac
dysrhythmias
restlessness

A

Graves Disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

sign present in 35% of patients with Graves dse

A

Exophthalmos (hypertrophy of eye muscles and increased connective tissue in the orbit)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

express TSH receptor-like proteins affected by thyroid-stimulating immunoglobulin

A

Orbital fibroblasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treatment for Autoimmune Thyroid Disease (AITDS)

A

daily oral thyroid hormone replacement therapy, with levothyroxine (T4)

radioactive iodine therapy, or surgery (thyroidectomy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Lab diagnosis for Autoimmune Thyroid Disease (AITDS)

A

TSH levels (chemiluminescent immunoassays - < 0.1 mU/L)

TSH Receptor Ab (TRAbs) – Graves dse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

selective destruction of beta cells of the pancreas; characterized by hyperglycemia

A

Type 1 Diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

associated HLA gene in T1 diabetes

A

HLA-DR3 or DR4 gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

T/F
hyperglycemia does not become evident until 80% or more of the beta cells are destroyed

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

it is central to disease pathogenesis of T1 diabetes

A

autoimmunity to insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Treatment for T1 diabetes

A

Daily injectable insulin
Beta Islet cell transplantation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How is T1 diabetes diagnosed?

A

if 1 of 4 criteria is met:
1. fasting glucose >126 mg/dL on <1 occasion (normal: < 100 mg/dL)
2. random plasma glucose level of >200 mg/dL with classic symptoms of diabetes
3. oral glucose tolerance test of >200 mg/dL in a 2-hour sample with a 75 g glucose load
4. hemoglobin A1c value (HbA1c) >6.5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

glycated form of hgb made when RBC protein combines with glucose in the blood.

A

HbA1c

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

HbA1c reflects the average plasma glucose concentration over the previous _____

A

2-3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Used for Confirmation of T1 diabetes diagnosis
antibodies to: glutamic acid decarboxylase (GAD) insulinoma-antigen 2 antibodies (IA-2A)
26
most sensitive tests and best positive predictive value for T1D in high-risk populations
Combined screening for IA-2A, ICA, GAD Ab
27
autoimmune disease affecting small intestine and other organs
Celiac Disease
28
Celiac Disease is associated with this known environmental trigger
dietary gluten
29
alleles in celiac disease
HLA-DQ2 (90% to 95%) HLA-DQ8
30
W:M in celiac dse
2-3:1
31
what makes celiac dse difficult of diagnose?
extraintestinal manifestations in older children, teenagers, adults
32
Treatment for Celiac dse
gluten-free diet
33
Laboratory Diagnosis for Celiac dse
IgA Ab detection to tTG biopsy of the small intestine HLA typing
34
serological method of choice for initial testing (ELISA based) of Celiac dse
IgA Ab detection to tissue transglutaminase (tTG)
35
3 Autoimmune Liver Diseases
autoimmune hepatitis (AIH) / chronic active hepatitis primary biliary cirrhosis (PBC) primary sclerosing cholangitis (PSC)
36
immune mediated liver disease that can lead to endstage liver failure if left untreated
Autoimmune Hepatitis (AIH)
37
2 types of AIH differentiated on the basis of its autoantibody specificity
AIH-1 AIH-2
38
2/3 of all AIH cases; W:M ratio = 4:1
AIH-1
39
W:M ratio = 10:1; seen mostly in children
AIH-2
40
alleles associated with a higher risk of developing AIH
HLA-DRB1 and HLA-DQB1
41
necessary to confirm the diagnosis of AIH and to assess the extent of liver damage
Liver biopsy
42
Treatment of AIH
standard immunosuppressive treatment of prednisolone (+/–azathioprine) liver transplant
43
most common autoimmune liver disease
Primary Biliary Cirrhosis (PBC)
44
W:M of Primary Biliary Cirrhosis (PBC)
10:1
45
haplotypes of Primary Biliary Cirrhosis (PBC)
HLA-DQA1 HLA-DQB1 HLADPB1 HLA-DRB1
46
involves progressive destruction of intrahepatic bile ducts
Primary Biliary Cirrhosis (PBC)
47
progressive destruction of intrahepatic bile ducts in Primary Biliary Cirrhosis (PBC) leads to
chronic cholestasis (flow of bile is slowed or blocked)
48
manifestation of later stages of PBC
jaundice ascites greasy stools
49
Treatment of PBC
ursodeoxycholic acid (UDCA) liver transplant
50
Diagnosis of PBC
Anti-mitochondrial antibodies (AMAs) - IIF and ELISA Elevated alkaline phosphatase - 1.5X the upper limit of normal for 6 months or more liver biopsy showing nonsuppurative destructive cholangitis and interlobular bile duct injury
51
autoimmune disorder involving CNS inflammation and destruction
Multiple Sclerosis
52
Multiple Sclerosis most closely associated with inheritance of a particular HLA molecule coding for beta chain of the DR subregion, namely
DRB1*1501
53
environmental factors associated with MS
reduced sunlight exposure vit D deficiency cigarette smoking
54
formation of lesions in MS in the white matter of brain and spinal cord, resulting in the progressive destruction of the myelin sheath of axons
plaques
55
specialized phagocytes of CNS
microglial cells
56
sensory abnormalities of MS
tingling or “pins and needles” flashes of light seen on eye movement
57
W:M of MS
2:1
58
Treatment of MS
corticosteroids (reduce inflammation) IFN-β1a and IFN-β1b (downregulate MHC molecules on APC) natalizumab (humanized monoclonal Ab)
59
Laboratory Diagnosis of Multiple Sclerosis
protein electrophoresis and immunoblotting (oligoclonal) IgG index = CSF IgG/albumin ÷ serum IgG/albumin (elevated)
60
autoimmune dse that affects neuromuscular junction; weakness and fatigability of skeletal muscles
Myasthenia Gravis (MG)
61
antibody-mediated damage to acetylcholine receptors in skeletal muscle
Myasthenia Gravis (MG)
62
S/S ptosis (drooping of the eyelids) diplopia (double vision) inability to retract corners of mouth: snarling appearance muscle weakness - most noticeable in the upper limbs
Myasthenia Gravis (MG)
63
antibody to acetylcholine (ACH) receptors (ACHR) in 80-85% of patients
MG
64
HLA haplotype that has a strong association with early onset MG (EOMG)
A1 B8 DR3
65
HLA haplotype which more likely to appear in late onset (LOMG)
B7 DR2
66
HLA that may increase susceptibility to muscle-specific kinase (MuSK) antibody production in MG
HLA-DR14-DQ5
67
Treatment of MG
Anticholinesterase agents (prevent destruction of neurotransmitter – acetylcholine) Thymectomy on patients with thymoma Plasmapheresis or IV immunoglobulin Monoclonal antibodies or fusion proteins
68
Lab Dx of MG
radioimmunoprecipitation (RIPA) assay - detected with a radio-labeled snake venom called α-bungaro-toxin) immunofluorescence cell-based assays (patient serum is incubated with HEK293 cells expressing all 4 ACHR subunits) ELISA, luciferase immunoprecipitation, fluorescence immunoprecipitation assays (FIPA)
69
presence of autoantibody to an antigen in the basement membranes in the glomeruli of kidneys and alveoli of lungs
Good Pasture's Syndrome
70
Good Pasture's Syndrome affects these 2 age grp
men in 30s men & women in 60s and 70s
71
rare disorder found mainly in Caucasians of European origin
Good Pasture's Syndrome
72
S/S: fatigue and malaise followed by clinical signs of kidney involvement such as edema and hypertension, which can rapidly progress to acute renal failure if left untreated; 60 – 70% of patients have pulmonary involvement and exhibit symptoms such as cough, shortness of breath, hemoptysis (coughing up blood)
Good Pasture's Syndrome
73
Treatment of GPS
high dose corticosteroids --> immunosuppressive drugs (cyclophosphamide) plasmapheresis lifetime hemodialysis or kidney transplantation
74
HLA antigen carried by GPS patients
HLA-DRB1-15
75
Etiology involves exposure to cigarette smoke & organic solvents; autoantibodies are specifically directed against noncollagenous domain of alpha-3 chain of type IV collagen; this autoantibody reacts with collagen in glomerular or alveolar basement membranes and causes damage by type II hypersensitivity
GPS
76
Lab Dx of GPS
▪ gross or microscopic hematuria ▪ proteinuria ▪ decreased 24-hour creatinine clearance ▪ elevated blood urea and serum creatinine levels ▪ abnormally shaped RBCs and casts in urine sediment
77
Circulating antibodies to GBM (Goodpasture Basement Membrane) can be identified through
IIF ELISA Western Blot
78
T/F ANCAs may be detectable months to years before antiGBM and symptoms are evident
T
79
pattern formed of patient with GPS condition in direct immunofluorescence of kidney and lung specimen
smooth, linear, ribbonlike
80
glomerulonephritis pattern on immunofluorescence? reason?
granular nonspecific deposition of immune complexes in the glomeruli